BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 23054877)

  • 1. Non-small cell lung cancer.
    Ettinger DS; Akerley W; Borghaei H; Chang AC; Cheney RT; Chirieac LR; D'Amico TA; Demmy TL; Ganti AK; Govindan R; Grannis FW; Horn L; Jahan TM; Jahanzeb M; Kessinger A; Komaki R; Kong FM; Kris MG; Krug LM; Lennes IT; Loo BW; Martins R; O'Malley J; Osarogiagbon RU; Otterson GA; Patel JD; Pinder-Schenck MC; Pisters KM; Reckamp K; Riely GJ; Rohren E; Swanson SJ; Wood DE; Yang SC; Hughes M; Gregory KM;
    J Natl Compr Canc Netw; 2012 Oct; 10(10):1236-71. PubMed ID: 23054877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-small cell lung cancer.
    Ettinger DS; Akerley W; Bepler G; Blum MG; Chang A; Cheney RT; Chirieac LR; D'Amico TA; Demmy TL; Ganti AK; Govindan R; Grannis FW; Jahan T; Jahanzeb M; Johnson DH; Kessinger A; Komaki R; Kong FM; Kris MG; Krug LM; Le QT; Lennes IT; Martins R; O'Malley J; Osarogiagbon RU; Otterson GA; Patel JD; Pisters KM; Reckamp K; Riely GJ; Rohren E; Simon GR; Swanson SJ; Wood DE; Yang SC;
    J Natl Compr Canc Netw; 2010 Jul; 8(7):740-801. PubMed ID: 20679538
    [No Abstract]   [Full Text] [Related]  

  • 3. Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    D'Addario G; Früh M; Reck M; Baumann P; Klepetko W; Felip E;
    Ann Oncol; 2010 May; 21 Suppl 5():v116-9. PubMed ID: 20555059
    [No Abstract]   [Full Text] [Related]  

  • 4. Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.
    Hanna N; Johnson D; Temin S; Baker S; Brahmer J; Ellis PM; Giaccone G; Hesketh PJ; Jaiyesimi I; Leighl NB; Riely GJ; Schiller JH; Schneider BJ; Smith TJ; Tashbar J; Biermann WA; Masters G
    J Clin Oncol; 2017 Oct; 35(30):3484-3515. PubMed ID: 28806116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Planchard D; Popat S; Kerr K; Novello S; Smit EF; Faivre-Finn C; Mok TS; Reck M; Van Schil PE; Hellmann MD; Peters S;
    Ann Oncol; 2018 Oct; 29(Suppl 4):iv192-iv237. PubMed ID: 30285222
    [No Abstract]   [Full Text] [Related]  

  • 6. Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology.
    Ettinger DS; Wood DE; Aisner DL; Akerley W; Bauman J; Chirieac LR; D'Amico TA; DeCamp MM; Dilling TJ; Dobelbower M; Doebele RC; Govindan R; Gubens MA; Hennon M; Horn L; Komaki R; Lackner RP; Lanuti M; Leal TA; Leisch LJ; Lilenbaum R; Lin J; Loo BW; Martins R; Otterson GA; Reckamp K; Riely GJ; Schild SE; Shapiro TA; Stevenson J; Swanson SJ; Tauer K; Yang SC; Gregory K; Hughes M
    J Natl Compr Canc Netw; 2017 Apr; 15(4):504-535. PubMed ID: 28404761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SEOM clinical guidelines for the treatment of non-small cell lung cancer (NSCLC) 2015.
    García-Campelo R; Bernabé R; Cobo M; Corral J; Coves J; Dómine M; Nadal E; Rodriguez-Abreu D; Viñolas N; Massuti B
    Clin Transl Oncol; 2015 Dec; 17(12):1020-9. PubMed ID: 26691657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarker Testing for Patients With Advanced Non-Small Cell Lung Cancer: Real-World Issues and Tough Choices.
    Pennell NA; Arcila ME; Gandara DR; West H
    Am Soc Clin Oncol Educ Book; 2019 Jan; 39():531-542. PubMed ID: 31099633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis, prognosis, and prediction of non-small cell lung cancer. Importance of morphology, immunohistochemistry and molecular pathology].
    Warth A
    Pathologe; 2015 Nov; 36 Suppl 2():194-200. PubMed ID: 26391251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Reck M; Popat S; Reinmuth N; De Ruysscher D; Kerr KM; Peters S;
    Ann Oncol; 2014 Sep; 25 Suppl 3():iii27-39. PubMed ID: 25115305
    [No Abstract]   [Full Text] [Related]  

  • 11. Recommendations for the analysis of ALK gene rearrangements in non-small-cell lung cancer: a consensus of the Italian Association of Medical Oncology and the Italian Society of Pathology and Cytopathology.
    Marchetti A; Ardizzoni A; Papotti M; Crinò L; Rossi G; Gridelli C; Barberis M; Maiorano E; Normanno N; Taddei GL; Scagliotti G; Clemente C; Pinto C
    J Thorac Oncol; 2013 Mar; 8(3):352-8. PubMed ID: 23407559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Non-small cell lung cancer. New biomarkers for diagnostics and therapy].
    Kayser G
    Pathologe; 2015 Nov; 36 Suppl 2():189-93. PubMed ID: 26391246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved outcomes and staging in non-small-cell lung cancer guided by a molecular assay.
    Gupta AR; Woodard GA; Jablons DM; Mann MJ; Kratz JR
    Future Oncol; 2021 Dec; 17(34):4785-4795. PubMed ID: 34435876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-small cell lung cancer, version 1.2015.
    Ettinger DS; Wood DE; Akerley W; Bazhenova LA; Borghaei H; Camidge DR; Cheney RT; Chirieac LR; D'Amico TA; Demmy TL; Dilling TJ; Govindan R; Grannis FW; Horn L; Jahan TM; Komaki R; Kris MG; Krug LM; Lackner RP; Lanuti M; Lilenbaum R; Lin J; Loo BW; Martins R; Otterson GA; Patel JD; Pisters KM; Reckamp K; Riely GJ; Rohren E; Schild S; Shapiro TA; Swanson SJ; Tauer K; Yang SC; Gregory K; Hughes M
    J Natl Compr Canc Netw; 2014 Dec; 12(12):1738-61. PubMed ID: 25505215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Composite anatomical-clinical-molecular prognostic model in non-small cell lung cancer.
    López-Encuentra A; López-Ríos F; Conde E; García-Luján R; Suárez-Gauthier A; Mañes N; Renedo G; Duque-Medina JL; García-Lagarto E; Rami-Porta R; González-Pont G; Astudillo-Pombo J; Maté-Sanz JL; Freixinet J; Romero-Saavedra T; Sánchez-Céspedes M; Gómez de la Camara A;
    Eur Respir J; 2011 Jan; 37(1):136-42. PubMed ID: 20817702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
    Ettinger DS; Wood DE; Aisner DL; Akerley W; Bauman JR; Bharat A; Bruno DS; Chang JY; Chirieac LR; D'Amico TA; DeCamp M; Dilling TJ; Dowell J; Gettinger S; Grotz TE; Gubens MA; Hegde A; Lackner RP; Lanuti M; Lin J; Loo BW; Lovly CM; Maldonado F; Massarelli E; Morgensztern D; Ng T; Otterson GA; Pacheco JM; Patel SP; Riely GJ; Riess J; Schild SE; Shapiro TA; Singh AP; Stevenson J; Tam A; Tanvetyanon T; Yanagawa J; Yang SC; Yau E; Gregory K; Hughes M
    J Natl Compr Canc Netw; 2022 May; 20(5):497-530. PubMed ID: 35545176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Advanced Non-Small Cell Lung Cancer in 2018.
    Doroshow DB; Herbst RS
    JAMA Oncol; 2018 Apr; 4(4):569-570. PubMed ID: 29494728
    [No Abstract]   [Full Text] [Related]  

  • 18. [Molecular diagnostics and imaging].
    Fink C; Fisseler-Eckhoff A; Huss R; Nestle U
    Onkologie; 2009; 32 Suppl 1():3-8. PubMed ID: 19521129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [National Clinical Practice Guidelines for the management of non-small cell lung cancer in early, locally advanced and metastatic stages. Extended version].
    Barrón-Barrón F; Guzmán-De Alba E; Alatorre-Alexander J; Aldaco-Sarvider F; Bautista-Aragón Y; Blake-Cerda M; Blanco-Vázquez YC; Campos-Gómez S; Corona-Cruz JF; Iñiguez-García MA; Lozano-Ruiz FJ; Maldonado-Magos F; de la Mata-Moya D; Martínez-Barrera LM; Ramos-Prudencio R; Rodríguez-Cid J; Rivera-Rivera S; Trejo-Rosales RR; Aguilar-Ortíz MR; Astudillo-de la Vega H; Barajas-Figueroa LJ; Barroso-Quiroga N; Blanco-Salazar A; Castillo-Ortega G; Domínguez-Parra LM; Enriquez-Aceves MI; Fernández-Orozco A; Figueroa-Morales MA; Green-Schneewiss L; González-Garay JA; González Ramírez-Benfield R; Guadarrama-Orozco A; Guerrero-Ixtlahuac J; Hernández-Barajas D; Hernández-Montes de Oca R; Kelly-García J; Lázaro-León M; Silva-Bravo F; Tellez-Becerra JL; Macedo-Pérez EO; Maza-Ramos G; Mayorga-Butrón JL; Montaño-Velázquez BB; Murillo-Medina K; Narváez-Fernández S; Ochoa-Carrillo FJ; Olivares-Beltrán G; Olivares-Torres C; Ponce de León-Castillo M; Ponce-Viveros MA; Rubio-Gutiérrez JE; Sáenz-Frías JA; Silva-Vivas JA; Santillán-Doherty P; Soto-Ávila JJ; Toledo-Buenrostro V; Vargas-Abrego B; Velasco-Hidalgo L; Zapata-Tarres MM; Quintero-Beuló G; Arrieta O
    Salud Publica Mex; 2019; 61(3):359-414. PubMed ID: 31276353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastatic NSCLC: Clinical, molecular, and therapeutic factors associated with long-term survival.
    Asselain B; Barrière JR; Clarot C; Vabre JP; Gentil Le Pecq B; Duval Y; Thomas P; Herman D; Grivaux M; Debieuvre D
    Respir Med Res; 2019 Nov; 76():38-44. PubMed ID: 31527016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.